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Abstract
Purpose: Aim was to evaluate the accuracy of computed
tomography colonography (CTC) for detection of colo-
rectal neoplasia in a Fecal Occult Blood Test (FOBT)
positive screening population.
Methods: In three different institutions, consecutive
FOBT positives underwent CTC after laxative free
iodine tagging bowel preparation followed by colonos-
copy with segmental unblinding. Each CTC was read by
two experienced observers. For CTC and for colonos-
copy the per-polyp sensitivity and per-patient sensitivity
and specificity were calculated for detection of carcino-
mas, advanced adenomas, and adenomas.
Results: In total 22 of 302 included FOBT positive
participants had a carcinoma (7%) and 137 had an
adenoma or carcinoma ‡10 mm (45%). CTC sensitivity
for carcinoma was 95% with one rectal carcinoma as
false negative finding. CTC sensitivity for advanced
adenomas was 92% (95% CI: 88–96) vs. 96% (95% CI:
93–99) for colonoscopy (P = 0.26). For adenomas and
carcinomas ‡10 mm the CTC per-polyp sensitivity was
93% (95% CI: 89–97) vs. 97% (95% CI: 94–99) for
colonoscopy (P = 0.17). The per-patient sensitivity for
the detection of adenomas and carcinomas ‡10 mm was
95% (95% CI: 91–99) for CTC vs. 99% (95% CI: 98–100)
for colonoscopy (P = 0.07), while the per-patient spec-
ificity was 90% (95% CI: 86–95) and 96% (95% CI: 94–
99), respectively (P < 0.001).
Conclusion: CTC with limited bowel preparation per-
formed in an FOBT positive screening population has
high diagnostic accuracy for the detection of adenomas
and carcinomas and a sensitivity similar to that of
colonoscopy for relevant lesions.
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Colorectal cancer screening is aimed mainly at detecting
advanced adenomas and early stage colorectal cancer [1].
Although a large part of adenomas will not develop into
a carcinoma, a specific subgroup of advanced adenomas
is believed to have an increased risk of developing into
carcinoma [2–4]. Such advanced adenomas are now
understood to include adenomas of 10 mm or larger and
adenomas with advanced histological features: villous
histology or high-grade dysplasia [5]. The removal of
these adenomas leads to a reduction in the expected
incidence of CRC [6]. Screening for colorectal neoplasia
and subsequent removal of adenomas identified through
screening can therefore reduce cancer mortality.
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DOI: 10.1007/s00261-009-9586-8In screening for colorectal cancer, the Fecal Occult
Blood Test (FOBT) is the only screening test with a
documented reduction in CRC-related mortality [7, 8]. It
is a cheap test, well accepted and has a high negative
predictive value [9]. Unfortunately, the FOBT has a
limited positive predictive value. Large randomized trials
have shown that the prevalence of carcinomas in an
FOBT positive screening population is between 5.6% and
17.7%, while the prevalence of adenomas ranges between
15% and 55% [8, 10–12]. These numbers indicate that a
large number of positive FOBTs are false positives: these
screening participants have a positive FOBT test but no
colorectal neoplasia.
In principle, CT colonography can image both
adenomas and carcinomas. In an FOBT positive
screening population, CT colonography might therefore
be able to detect all relevant lesions that should be re-
moved or that need follow-up. As a consequence, CT
colonography might be used as a triage instrument in
FOBT positives, but in our previous study this did not
seem efﬁcient [13]. Another possibility is to use CT
colonography only in patients that are unfit for or are
unwilling to undergo colonoscopy. All screening par-
ticipants with a positive FOBT without relevant lesions
at CT colonography could then be safely withheld
colonoscopy.
Recent studies have reported a high sensitivity for the
detection of colorectal neoplasia on CT colonography in
average risk screening participants [14–16]. One recent
study investigated the accuracy of CT colonography in
FOBT positives (no screening) and found a sensitivity of
87% for advanced neoplasia [17]. Another study found
lesions 6 mm and larger in 40% of patients at CT colo-
nography in an FOBT screening population [18].
Colonoscopy was not performed in all patients, so no
accuracy could be calculated. Up to our knowledge no
previous study has assessed the accuracy of CT colo-
nography for detection of advanced neoplasia in popu-
lation-based FOBT screening.
The main aim of the present study was to assess the
sensitivity and speciﬁcity of CT colonography with a
limited bowel preparation for detecting colorectal neo-
plasia in an FOBT positive screening population.
Methods
Study population
Data were collected in an invitational FOBT pilot
screening trial in the Netherlands. A cohort of approxi-
mately 30,000 individuals between 50 and 75 years was
randomly allocated to receive either an immunochemical
test with a 50 ng/mL cut-off (I-FOBT, OC-sensor, Eiken
Chemical Co, Tokyo, Japan) or a non-rehydrated guaiac
test (G-FOBT; Haemoccult II, Beckman Coulter, Ful-
lerton, CA) [12, 19]. Details about the invitation, par-
ticipant recruitment, and evaluation of eligibility have
been described in detail elsewhere [13].
All FOBT positives invited to undergo colonoscopy
at the gastroenterology department were asked to un-
dergo additionally CT colonography before colonos-
copy. Excluded were participants with a terminal illness,
those who had had a colonoscopy or an FOBT in the
previous 2 years, inﬂammatory bowel disease or an
examination with radiation exposure in the last
12 months, participants with hyperthyroidism, with an
iodine contrast allergy or a pregnancy, as well those
persons unable to give informed consent. Institutional
review board approval was obtained before study initi-
ation. Eligible participants were informed about the
study purpose and asked for written consent.
CT colonography
Bowel preparation. The ﬁrst 153 participants received a 2-
day preparation with ingestion of 7 times 50 mL high-
osmolar ionic monomer meglumine-ioxithalamate dur-
ing meals (Telebrix Gastro 300 mg I/mL; Guerbet, Ce-
dex, France) and a low-ﬁber diet. The other 149
participants received a 1-day preparation with 4 times
50 mL of meglumine-ioxithalamate and a low-ﬁber diet.
No laxatives were used and patients were encouraged to
drink additional glasses of water. The reason to reduce
the amount of ingested contrast agent during this study
was that new studies on CT colonography bowel prep-
aration showed that image quality and polyp detection
remained sufﬁcient with only 1 day of bowel preparation
[20–22]. After evaluation we found that both prepara-
tions had a high acceptance and good image quality [23].
CT colonography examination. Scans were made on two
64-slice CT scanners in supine and prone position. The
scan protocol for the ﬁrst scanner (Brilliance, Philips
Medical Systems, Best, the Netherlands) was: 120 kV,
pitch 1.2, rotation time 0.4 s and a 40 reference mAs with
dose-modulation. For the other scanner (SOMATOM
Sensation, Siemens Medical Solutions, Erlangen, Ger-
many) this was: 120 kV, 1.4, 0.5 s, and 32 reference mAs
with dose-modulation. Before starting the insufﬂation, a
smooth muscle-relaxant (20 mg of butylscopalamine
bromide (Buscopan; Boehringer-Ingelheim, Ingelheim,
Germany)) was injected intravenously. When contrain-
dicated 1 mg of glucagon hydrochloride was injected
intravenously (Glucagen; Novo-Nordisk, Bagsvaerd,
Denmark). In participants with contraindications for
both smooth muscle-relaxants, no bowel relaxant was
administrated. CO2 gas was insufflated into the colon
using a flexible balloon-tipped rectal catheter (20 French
Gauge) using an automated insufflator (ProtoCO2l,
Bracco Diagnostics, Princeton, NY). The total amount
of CO2 insufflated and the in-room time were noted per
participant.
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on a workstation with specialized software (View Forum,
Philips Medical Systems, Best, the Netherlands; Aquar-
ius Workstation, TeraRecon, STAD, USA). A primary
2D axial evaluation (window setting 1500, -250 HU)
was done with 3D problem solving. Additionally a quick
uni-directional 3D ﬂy through was performed after the
primary 2D evaluation. Electronic cleansing software
was not available. Lesions were identiﬁed at each CT
colonography by two out of seven experienced observers
(radiologists and research fellows) who had evaluated at
least 100 CT colonographies with colonoscopic veriﬁca-
tion (range 100–700 CT colonographies). All observers
had passed a CT colonography exam with 25 cases by
scoring above a predeﬁned sensitivity threshold of 90%
for lesions ‡10 mm. The observers reported observing
time per viewing method (2D or 3D). The maximal
diameter of each lesion was measured by using electronic
calipers applied to a multiplanar reformatted (MPR)
setting. The location, morphology, size, and probability
were noted for each lesion. According to the Paris cri-
teria, ﬂat polyps were deﬁned as lesions that protrude less
than 2.5 mm from the mucosa [24]. Both observers
scored distension (four-point scale: 1 poorly distended to
4 good distension) and quality of bowel preparation
(five-point scale: 1 very inhomogeneous tagging to 5
excellent preparation). When one of these was judged
insufficient (score 1 or 2) by both readers in both scans,
the participant was excluded for analysis.
Colonoscopy
Colonoscopy was planned within 3 weeks after CT col-
onography. Four liters of polyethylene glycol electrolyte
solution (KleanPrep; Helsinn Birex Pharmaceuticals,
Dublin, Ireland) or 4 L of macrogol solution (Colofort;
Laboratoires Macors, Auxerre, France) and a clear li-
quid diet the preceding evening were used for colonos-
copy. The examination was performed by experienced
gastroenterologists, gastroenterology fellows and colon-
oscopy nurses with supervision, using a standard colon-
oscope (Olympus Medical Systems Europe, Hamburg
Germany). With the segmental unblinding technique,
lesions 6 mm or larger found at CT colonography were
revealed to the colonoscopist by a research fellow [ML]
after completing the examination of one segment. Col-
onoscopies were videotaped starting from the cecum.
The colonoscopist estimated lesion size by an opened
biopsy forceps or by a linear measure probe (Olympus
Medical Systems Europe, Hamburg Germany). Histol-
ogy of lesions was classiﬁed as normal, inﬂammatory,
hyperplastic, adenoma (serrated, tubular, tubolovillous,
or villous), or carcinoma [25]. Advanced neoplasias were
defined as adenomas 10 mm or larger in diameter, with a
villous architecture or high-grade dysplasia on histology,
or an invasive carcinoma [5].
Polyp matching
Matching of all lesions and tumors of 6 mm and larger
found on CT colonography was done by a research fel-
low [ML] by reviewing the colonoscopy video’s and re-
ports. Colonoscopy with segmental unblinding served as
an enhanced reference standard. A lesion on CT colo-
nography was classiﬁed as a true positive when colo-
nography and colonoscopy lesion size were within 50%
margin, lesions were in the same or adjacent segment and
the morphology at CT colonography resembled mor-
phology of the lesion seen on the videotaped colonos-
copy. Lipoma and normal mucosa were considered false
positives for CT colonography when scored as a lesion
by the CT colonography observer. False negative lesions
at CT colonography could be due to a perceptive error or
a technical error. Perceptive errors were visible on ret-
rospect at CT colonography, whereas technique related
errors were not.
Statistical analysis
The results of the two observers were combined in a
double reading procedure. If at least one observer had
detected a lesion this was considered a positive ﬁnding.
We also calculated the mean result for both observers.
The CT colonography per-polyp sensitivity was cal-
culated by using all true positive lesions at CT colo-
nography and the false negative lesions found at
colonoscopy. This was done separately for adenomatous
polyps and for carcinomas ‡10 mm, for adenomas and
carcinomas between 6 and 9 mm, as well as for all lesions
in these size categories, also including hyperplastic and
inflammatory polyps. In addition, we evaluated the per-
polyp sensitivity for advanced neoplasia and per lesion
morphology, classified as flat, sessile, or pedunculated.
Differences were tested with the Chi-square test statistic.
The per-polyp sensitivity of colonoscopy was calculated
by using the true positive and false negative lesions,
found after unblinding of the CT colonography results.
Comparisons between CT colonography and colonos-
copy sensitivity and influence of additional 3D reading
were evaluated using the McNemar test statistic.
The per-patient sensitivity was defined as the number
of participants with at least one true positive adenoma or
a carcinoma ‡10 and ‡6 mm at CT colonography rela-
tive to all participants with an adenoma or carcinoma in
that size category identified after colonoscopy with seg-
mental unblinding. The per-patient specificity was de-
fined as the number of participants negative on CT
colonography relative to all participants with a negative
colonoscopy result. A participant with both one true
positive and one false negative finding at CT colonog-
raphy was defined as a true positive. All non-adenoma-
tous lesions were counted as false positives, also for the
calculation of the colonoscopy specificity.
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kappa statistics with corresponding 95% confidence
intervals for the two readers and by calculating the total
number of concordant cases. The two reviewers were
considered to agree if they both recorded at least one true
lesion in the same participant or if both recorded no
findings. The kappa values were interpreted as follows:
<0.20 poor agreement; 0.21–0.40 fair; 0.41–0.60 mod-
erate; 0.61–0.80 good; 0.81–1.00 excellent. All calcula-
tions were performed using a statistical software package
(SPSS for Windows version 15.0.1, Chicago, IL).
Results
A total of 314 FOBT positive participants underwent CT
colonography before colonoscopy between June 2006
and May 2008. Twelve participants had an incomplete
CT colonography or colonoscopy. In two colonoscopies
the cecum was not reached because of extreme pain and a
colonic stricture. In four CT colonographies the bowel
preparation was insufﬁcient and in six the distension was
insufﬁcient. Finally 302 participants could be included in
the analysis (54 guaiac FOBT, 248 immunochemical
FOBT). Totally 187 males and 115 females were included
(see article [13], for additional demographic characteris-
tics and a flow-diagram of the study).
Colonoscopy
Colonoscopy was successful in 312 participants. One
participant (0.3%) had a bleeding after polypectomy for
which hospitalization was required. With colonoscopy 22
carcinomas were detected in 22 participants (7%), two
carcinomas were smaller than 10 mm; 184 adenomas and
carcinomas 10 mm or larger were detected in 137 par-
ticipants (45%). Another 138 adenomas and carcinomas
between 6 and 9 mm were detected in 60 participants
(20%). In total 180 advanced adenomas were found, of
which 164 were 10 mm or larger. Furthermore, three
lipomas and one hamartoma were found. Table 1 sum-
marizes the distribution of lesions according to size and
morphology. Lesions with no histology available were
not considered as an adenoma or carcinoma. Six ade-
nomas ‡10 mm were found with colonoscopy only after
unblinding of the CT colonography results. The latter
also resulted in 8 lesions between 6 and 9 mm that were
additionally found, of which 4 were adenomas. In Ta-
ble 2 the per-polyp sensitivity for colonoscopy is pre-
sented.
CT colonography
The mean in-room time for CT colonography was 21¢58¢¢
(SD 7¢20¢¢) per participant. In total, 260 participants
(86%) received an intravenous injection of Buscopan
while 29 (9.7%) received Glucagen. The average amount
of CO2 insufflated was 4.1L (SD 2.1L). No complications
were associated with the CT colonography examination.
The mean reading time for the 2D read was 10¢43¢¢ (SD
5¢21¢¢) and the additional 3D accounted for 4¢16¢¢ (SD
1¢30¢¢).
Per-polyp analysis. Of the 22 detected cancers at colon-
oscopy, 21 were also found at CT colonography with
double reading, resulting in a sensitivity of 97% (95% CI:
87–100). The one missed colorectal cancer was aﬂat rectal
carcinoma of 20 mm, hardly visible in retrospect (see
Fig. 1). CT colonography detected 171 of 184 adenomas
and carcinomas ‡10 mm (sensitivity 93%;9 5 % CI: 89–
97). This was not significantly different from the colon-
oscopy sensitivity (P = 0.17). See Table 2 for results on
per-polyp sensitivity of CT colonography compared to
colonoscopy. For lesions ‡10 mm CT colonography
sensitivity was 92% (95% CI: 88–96), which was lower
than the colonoscopy sensitivity (P = 0.035).
In this study, 165 of the 180 advanced adenomas were
detected at CT colonography, resulting in an estimated
sensitivity of 92% (95% CI: 88–96The colonoscopy sen-
sitivity for advanced adenomas was 96% (95% CI: 93–99)
(P = 0.26). In Table 3 the sensitivity of CT colonogra-
phy per morphology and size category is given sepa-
rately. CT colonography sensitivity in detecting flat
lesions was lower than that of pedunculated lesions in
both size categories (P < 0.001). The sensitivity of ses-
sile lesions 6–9 mm was lower than that for pedunculated
lesions (P < 0.01). Figures 2 and 3 show examples of a
pedunculated and flat lesion found at CT colonography
and colonoscopy.
In Table 4, the false negatives are categorized in false
negatives due to perspective error and false negatives due
to technical error. The largest percentage of technical
false negatives consisted of flat lesions (5 out of 14 flat
lesions; 36% for ‡10 mm and 8 out of 19; 42% for 6–
9 mm).
Table 1. Distribution of adenomatous or non-adenomatous lesions per
size category and per type of morphology
<6 mm 6–9 mm ‡10 mm
Pedunculated
Adenoma or carcinoma 22 40 109
All lesion types
a 24 45 118
Sessile
Adenoma or carcinoma 228 86 63
All lesion types
a 418 126 76
Flat
Adenoma or carcinoma 23 12 12
All lesion types
a 46 19 14
Total
All polyps and carcinomas 488 190 208
a All lesion types: adenomas, carcinomas, hyperplastic, hamartomous
or infectious lesions. These also include polyps that were lost after
polypectomy and polyps with unclear histology
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seen at secondary 3D reading only. Of these lesions, four
had a ﬂat histology, eleven were sessile, and one
pedunculated. The additional 3D read detected lesions
increased the sensitivity from 67% (95% CI: 60–74) to
75% (95% CI: 69–81) for lesions between 6 and 9 mm
(P < 0.000), without a similar increase for lesions
‡10 mm: 91% (95% CI: 88–95) vs. 92% (95% CI: 88–96)
(P = 1).
Per-patient sensitivity and speciﬁcity. In Table 5 the CT
colonography and colonoscopy sensitivity and CT colo-
nography specificity per patient for adenomas and car-
cinomas of both size categories are given. The per-patient
sensitivity of CT colonography was 95% (95% CI: 91–99)
for adenomas and carcinomas ‡10 mm and 93% (95%
CI: 89–96) for adenomas ‡6 mm. The specificity for the
identification of participants without any adenoma or
carcinoma of ‡10 mm was 90% (95% CI: 86–95), for
‡6 mm this was 70% (95% CI: 62–79). Comparing CT
colonography and colonoscopy no significant difference
was found in the sensitivity for adenomas and carcino-
mas ‡10 mm.
Interobserver agreement. For per-patient analysis for le-
sions ‡10 mm, a kappa value of 0.90 (95% CI, 0.85–0.94)
was calculated for the interobserver agreement. For le-
sions ‡6 mm this was 0.82 (95% CI, 0.76–88).
Table 2. Per-polyp sensitivity for CT colonography compared to colonoscopy
Sensitivity CT colonography Colonoscopy P values
Advanced adenomas 92% (88–96) 96% (93–99) P = 0.26
165/178 173/180
Adenomas and carcinomas 6–9 mm 78% (71–85) 97% (94–100) P < 0.001
108/138 134/138
Adenomas and carcinomas ‡10 mm 93% (89–97) 97% (94–99) P = 0.17
171/184 178/184
All lesions
a 6–9 mm 75% (69–81) 96% (93–99) P < 0.001
142/190 190/198
All lesions
a ‡10 mm 92% (88–96) 97% (95–99) P = 0.035
191/208 208/214
a All lesion types: adenoma, carcinoma, hyperplasia, hamartomous or infectious. Also includes not-removed polyps and polyps with unclear
histology. Between brackets is the 95% confidence interval
Fig. 1. False negative rectal carcinoma images of the su-
pine (A) and prone scans (B) of a patient with a rectal carci-
noma. This lesion was not detected at CT colonography by
both observers and retrospectively hardly visible. Arrows
indicate the tumor seen at CT colonography and colonoscopy
(C).
Table 3. Per-polyp sensitivity of CT colonography per size category
and per lesion type for adenomatous polyps and for all histology types
(double read)
6–9 mm ‡10 mm
Pedunculated
Adenomas and carcinomas 95% (88–100) 95% (91–99)
38/40 104/109
All lesions
a 96% (90–100) 95% (91–99)
43/45 112/118
Sessile
Adenomas and carcinomas 76% (67–85)* 95% (90–100)
65/86 60/63
All lesions
a 71% (64–79)* 93% (88–99)*
90/126 71/76
Flat
Adenomas and carcinomas 42% (14–70)* 58% (30–86)*
5/12 7/12
All lesions
a 47% (25–70)* 57% (31–83)*
9/19 8/14
a All lesion types: adenoma, carcinoma, hyperplasia, hamartomous or
infectious. Also includes not-removed polyps and polyps with unclear
histology. Between brackets is the 95% confidence interval
* Significantly different sensitivity compared to the pedunculated le-
sions P < 0.05
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In the Joint Guideline for screening on colorectal cancer
from the American Cancer Society, the US Multi-Society
Task Force on Colorectal Cancer, and the American
College of Radiology a number of alternative colorectal
screening tests are recommended, including the FOBT
[9]. The FOBT is a cheap and simple screening test for
colorectal cancer with a high negative predictive value,
but it has the disadvantage that it generates a large
number of false positives, resulting in lower positive
predictive value which will result in a higher number of
unnecessary invasive colonoscopic examinations. Ours is
the first study to investigate the diagnostic accuracy of
CT colonography for detection of colorectal neoplasia in
an FOBT positive screening population. In the present
study there was a high prevalence of colorectal neoplasia
in the FOBT positive participants: almost two-thirds of
all participants had one or more adenomas or a carci-
noma. The vast majority of these lesions were detected by
the CT colonography readers resulting in a high sensi-
tivity for detection of adenomas and carcinomas.
In a recent study of Regge et al. [17], the per-patient
sensitivity for detection of advanced neoplasia of 6 mm
Fig. 2. Pedunculated tubulovillous adenoma 15 mm, submerged in tagged feces: A is an MPR view of the supine position, B
the axial supine view, C the lesion is removed at colonoscopy.
Fig. 3. Flat serrated adenoma 12 mm. This flat adenoma was detected by both CT colonography observers: A is the 2D axial
image of the prone scan and B is the 3D view. Arrows indicate the flat lesion, C is the lesion seen at colonoscopy.
Table 4. Number of false negatives per size category and per lesion type
6–9 mm ‡10 mm
Perceptive false negative
Pedunculated 0 (0%) 2 (1.7%)
Sessile 7 (5.6%) 1 (1.3%)
Flat 2 (10.5%) 2 (14.3%)
Technical false negative
Pedunculated 2 (4.4%) 3 (2.6%)
Sessile 28 (22.4%) 2 (2.7%)
Flat 8 (42.1%) 5 (35.7%)
Percentages are the number of false negatives related to the total
number of lesions of this type






CTC double read 93% (89–96)* 95% (91–99)
CTC mean 2 readers 89% (85–94)* 92% (88–97)*
Colonoscopy 98% (96–100) 99% (98–100)
Specificity
CTC double read 70% (62–79)* 90% (86–95)*
CTC mean 2 readers 77% (69–85)* 93% (90–97)*
Colonoscopy 93% (89–98) 96% (94–99)
Lesions that were not adenomatous or carcinoma were counted as false
positive. Between brackets is the 95% confidence interval
* Indicates significant difference compared to colonoscopy
CTC, CT colonography
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is comparable to the sensitivity we found in our study.
Also the specificity was similar; in both studies this was
77% (mean percentage of all readers). The FOBT posi-
tives in the previous study were no screening partici-
pants, but increased risk patients that could already have
had symptoms. This is different than in our study that
included FOBT positives from a population screening
program. Furthermore, when compared to earlier studies
that evaluated CT colonography for adenoma detection
in screening participants, we found a similar sensitivity
and specificity [14, 16, 26]. In these studies, sensitivities
for detection of adenomas and carcinomas ‡10 mm were
90% or more. Different than in our study, these studies
contained average risk screening participants with a low
lesion prevalence and all patients received an extensive
cathartic bowel preparation. When using a limited bowel
preparation, we found a sensitivity of 93% for detection
of colorectal neoplasia ‡10 mm in FOBT positive
screened participants, not significantly different than the
sensitivity of colonoscopy (97%). For the detection of
advanced adenomas, CT colonography had a sensitivity
similar to that of colonoscopy.
The prevalence of lesions is an important issue when
evaluating the use of a diagnostic test in screening partici-
pants. In the present study there was a high lesion preva-
lence in the FOBT positive group, almost 65% of all
positives had an adenoma or carcinoma of 6 mm and lar-
ger. Therefore, the CT colonography does not seem an
effective triage instrument in FOBT positives (see [13]), but
becauseofthehighsensitivityitmighthavearoleinpatients
with severe comorbidities that are unfit to undergo colon-
oscopy or patients unwilling to undergo colonoscopy.
The per-patient speciﬁcity for the detection of large
lesions was lower than that of colonoscopy, 90% vs. 96%.
For the medium size category (6–9 mm) we found a
sensitivity of 78% which was signiﬁcantly lower than that
of colonoscopy. One ﬂat rectal carcinoma was missed at
CT colonography and was even retrospectively hardly
visible. It is already known from earlier studies that le-
sions with a ﬂat morphology are easily missed at CT
colonography [27, 28]. Furthermore, the rectum is a
difficult colonic segment to examine because the disten-
sion is not always optimal, especially not in supine po-
sition, and an inflated rectal balloon can mask rectal
lesions [29, 30]. One previous paper described a malig-
nant rectal lesion missed due to the presence of the in-
flated balloon [31]. A digital rectal examination could be
performed to reduce the number of false negative rectal
lesions in this segment. Its feasibility in clinical practice is
questionable because a digital rectal examination has to
be performed by an experienced person. In many centers
CT colonography is performed independently by radi-
ographers.
We found in the present study that sensitivity for
detection of pedunculated lesions was high at CT colo-
nography. For lesions ‡10 mm the sensitivity in detect-
ing ﬂat lesions was signiﬁcantly lower than the
sensitivity in detecting pedunculated and sessile lesions.
Most of the false negative lesions were not visible ret-
rospectively and have to be considered as technically
false negatives. In this population the number of ﬂat
lesions was low, so this did not greatly affect CT colo-
nography polyp sensitivity.
Each CT colonography was examined by two
observers and their results were combined. This double
reading procedure is time consuming but it resulted in a
higher per-patient sensitivity. This was also found in a
previous study by Johnson et al. [32]. A disadvantage of
this double reading is that the number of false positives
increases as well, consequently, the per-patient specificity
decreases. The mean specificity of both readers for ade-
nomas and carcinomas ‡6m mi s7 7 % compared to a
70% specificity for the double read. In this high lesion
prevalence FOBT positive population it is important to
obtain a high sensitivity so participants are not wrongly
withheld colonoscopy.
Another method to improve the sensitivity of CT
colonography is the use of an additional 3D reading after
the primary 2D reading. We found that for detection of
lesions between 6 and 9 mm, the sensitivity increased
when using 3D reading after the 2D reading. In partic-
ular additional sessile and ﬂat lesions were found after
3D viewing. Flat lesions are easily missed and probably
best detected at a 3D viewing method [28]. A previous
study showed that an additional 3D read resulted in a
higher sensitivity for detection of polyps [33]. The main
reason for not performing a primary 3D and evaluating a
primary 2D review method only in the present study was
the use of a limited bowel preparation without having the
availability of a cleansing algorithm.
A potential limitation of the present study is that we
changed the bowel preparation after half of the partici-
pants had received a CT colonography. This was done
because articles had been published during the study
period indicating that a 1-day bowel preparation was
sufﬁcient for qualitative fecal tagging, simultaneously
reducing patient burden [20–22]. We retrospectively
compared the quality of the bowel preparation in the 2-
and 1-day preparation groups and found no differences
in homogeneity of stool and detection of polyps while
participant acceptance increased [23]. Another potential
limitation is that due to a limited bowel preparation an
immediate colonoscopy after a positive CT colonogra-
phy is not possible. In our opinion, however, the
advantage of an improved patient acceptance is more
important than this disadvantage. Furthermore, we did
not use a consensus read between the two observers. The
main reasons for this were that we wanted to reduce time
spent on examining the CT colonographies and we aimed
to obtain a high sensitivity by combining the scores of
both observers.
M. H. Liedenbaum et al.: CT colonography with limited bowel preparation 667In conclusion we found that CT colonography has a
high diagnostic accuracy for detection of colorectal
neoplasia in an FOBT positive screening population.
Even with the use of a limited bowel preparation, the
sensitivity of CT colonography for detection of large
adenomas and carcinomas in our study was similar to
that of colonoscopy and therefore CT colonography can
be used in FOBT positives that are unﬁt for or unwilling
to undergo colonoscopy. Double reading and additional
3D reading increased the sensitivity of CT colonography.
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